Synergy Therapeutics Inc.
Synergy Therapeutics Inc.
Categories
Biotechnology
About
Synergy Therapeutics, a small start-up out of Saint Joseph’s University/Philadelphia College of Pharmacy, is developing ch-p53HSA, the first in class dual agonist/antagonist cholestosome formulated peptide for use in synergistic combination with Kinase Inhibitors.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.